The global Point of Care & Rapid Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The report includes an overview of the development of the Point of Care & Rapid Diagnostics industry chain, the market status of Hospital (Rapid Test, Molecular Diagnostics), Home Care (Rapid Test, Molecular Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point of Care & Rapid Diagnostics.
Regionally, the report analyzes the Point of Care & Rapid Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point of Care & Rapid Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point of Care & Rapid Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point of Care & Rapid Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Rapid Test, Molecular Diagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point of Care & Rapid Diagnostics market.
Regional Analysis: The report involves examining the Point of Care & Rapid Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point of Care & Rapid Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point of Care & Rapid Diagnostics:
Company Analysis: Report covers individual Point of Care & Rapid Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point of Care & Rapid Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Home Care).
Technology Analysis: Report covers specific technologies relevant to Point of Care & Rapid Diagnostics. It assesses the current state, advancements, and potential future developments in Point of Care & Rapid Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point of Care & Rapid Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point of Care & Rapid Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Rapid Test
Molecular Diagnostics
Market segment by Application
Hospital
Home Care
Market segment by players, this report covers
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioM茅rieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Point of Care & Rapid Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point of Care & Rapid Diagnostics, with revenue, gross margin and global market share of Point of Care & Rapid Diagnostics from 2019 to 2024.
Chapter 3, the Point of Care & Rapid Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Point of Care & Rapid Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Point of Care & Rapid Diagnostics.
Chapter 13, to describe Point of Care & Rapid Diagnostics research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Point of Care & Rapid Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point of Care & Rapid Diagnostics by Type
1.3.1 Overview: Global Point of Care & Rapid Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Point of Care & Rapid Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Rapid Test
1.3.4 Molecular Diagnostics
1.4 Global Point of Care & Rapid Diagnostics Market by Application
1.4.1 Overview: Global Point of Care & Rapid Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Home Care
1.5 Global Point of Care & Rapid Diagnostics Market Size & Forecast
1.6 Global Point of Care & Rapid Diagnostics Market Size and Forecast by Region
1.6.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Point of Care & Rapid Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Point of Care & Rapid Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Point of Care & Rapid Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Point of Care & Rapid Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Point of Care & Rapid Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Point of Care & Rapid Diagnostics Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Johnson and Johnson
2.1.1 Johnson and Johnson Details
2.1.2 Johnson and Johnson Major Business
2.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Product and Solutions
2.1.4 Johnson and Johnson Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Johnson and Johnson Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Product and Solutions
2.2.4 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Bio-Techne
2.3.1 Bio-Techne Details
2.3.2 Bio-Techne Major Business
2.3.3 Bio-Techne Point of Care & Rapid Diagnostics Product and Solutions
2.3.4 Bio-Techne Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bio-Techne Recent Developments and Future Plans
2.4 Roche Diagnostics
2.4.1 Roche Diagnostics Details
2.4.2 Roche Diagnostics Major Business
2.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Product and Solutions
2.4.4 Roche Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Roche Diagnostics Recent Developments and Future Plans
2.5 Siemens Healthineers
2.5.1 Siemens Healthineers Details
2.5.2 Siemens Healthineers Major Business
2.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Product and Solutions
2.5.4 Siemens Healthineers Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Siemens Healthineers Recent Developments and Future Plans
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business
2.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Product and Solutions
2.6.4 Abbott Laboratories Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Laboratories Recent Developments and Future Plans
2.7 Danaher Corporation
2.7.1 Danaher Corporation Details
2.7.2 Danaher Corporation Major Business
2.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Product and Solutions
2.7.4 Danaher Corporation Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Danaher Corporation Recent Developments and Future Plans
2.8 BD
2.8.1 BD Details
2.8.2 BD Major Business
2.8.3 BD Point of Care & Rapid Diagnostics Product and Solutions
2.8.4 BD Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BD Recent Developments and Future Plans
2.9 Sysmex
2.9.1 Sysmex Details
2.9.2 Sysmex Major Business
2.9.3 Sysmex Point of Care & Rapid Diagnostics Product and Solutions
2.9.4 Sysmex Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sysmex Recent Developments and Future Plans
2.10 Cardinal Health
2.10.1 Cardinal Health Details
2.10.2 Cardinal Health Major Business
2.10.3 Cardinal Health Point of Care & Rapid Diagnostics Product and Solutions
2.10.4 Cardinal Health Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Cardinal Health Recent Developments and Future Plans
2.11 Quidel
2.11.1 Quidel Details
2.11.2 Quidel Major Business
2.11.3 Quidel Point of Care & Rapid Diagnostics Product and Solutions
2.11.4 Quidel Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Quidel Recent Developments and Future Plans
2.12 GE Healthcare
2.12.1 GE Healthcare Details
2.12.2 GE Healthcare Major Business
2.12.3 GE Healthcare Point of Care & Rapid Diagnostics Product and Solutions
2.12.4 GE Healthcare Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 GE Healthcare Recent Developments and Future Plans
2.13 EKF Diagnostics
2.13.1 EKF Diagnostics Details
2.13.2 EKF Diagnostics Major Business
2.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Product and Solutions
2.13.4 EKF Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 EKF Diagnostics Recent Developments and Future Plans
2.14 bioM茅rieux SA
2.14.1 bioM茅rieux SA Details
2.14.2 bioM茅rieux SA Major Business
2.14.3 bioM茅rieux SA Point of Care & Rapid Diagnostics Product and Solutions
2.14.4 bioM茅rieux SA Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 bioM茅rieux SA Recent Developments and Future Plans
2.15 Accubiotech
2.15.1 Accubiotech Details
2.15.2 Accubiotech Major Business
2.15.3 Accubiotech Point of Care & Rapid Diagnostics Product and Solutions
2.15.4 Accubiotech Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Accubiotech Recent Developments and Future Plans
2.16 PTS Diagnostics
2.16.1 PTS Diagnostics Details
2.16.2 PTS Diagnostics Major Business
2.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Product and Solutions
2.16.4 PTS Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 PTS Diagnostics Recent Developments and Future Plans
2.17 Chembio Diagnostics
2.17.1 Chembio Diagnostics Details
2.17.2 Chembio Diagnostics Major Business
2.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Product and Solutions
2.17.4 Chembio Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Chembio Diagnostics Recent Developments and Future Plans
2.18 Trinity Biotech
2.18.1 Trinity Biotech Details
2.18.2 Trinity Biotech Major Business
2.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Product and Solutions
2.18.4 Trinity Biotech Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Trinity Biotech Recent Developments and Future Plans
2.19 Sekisui Diagnostics
2.19.1 Sekisui Diagnostics Details
2.19.2 Sekisui Diagnostics Major Business
2.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Product and Solutions
2.19.4 Sekisui Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Sekisui Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Point of Care & Rapid Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Point of Care & Rapid Diagnostics by Company Revenue
3.2.2 Top 3 Point of Care & Rapid Diagnostics Players Market Share in 2023
3.2.3 Top 6 Point of Care & Rapid Diagnostics Players Market Share in 2023
3.3 Point of Care & Rapid Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Point of Care & Rapid Diagnostics Market: Region Footprint
3.3.2 Point of Care & Rapid Diagnostics Market: Company Product Type Footprint
3.3.3 Point of Care & Rapid Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Point of Care & Rapid Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Point of Care & Rapid Diagnostics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Point of Care & Rapid Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Point of Care & Rapid Diagnostics Market Forecast by Application (2025-2030)
6 North America
6.1 North America Point of Care & Rapid Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Point of Care & Rapid Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Point of Care & Rapid Diagnostics Market Size by Country
6.3.1 North America Point of Care & Rapid Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Point of Care & Rapid Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country
7.3.1 Europe Point of Care & Rapid Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Point of Care & Rapid Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region
8.3.1 Asia-Pacific Point of Care & Rapid Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
9 South America
9.1 South America Point of Care & Rapid Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Point of Care & Rapid Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Point of Care & Rapid Diagnostics Market Size by Country
9.3.1 South America Point of Care & Rapid Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Point of Care & Rapid Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country
10.3.1 Middle East & Africa Point of Care & Rapid Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Point of Care & Rapid Diagnostics Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Point of Care & Rapid Diagnostics Market Drivers
11.2 Point of Care & Rapid Diagnostics Market Restraints
11.3 Point of Care & Rapid Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Point of Care & Rapid Diagnostics Industry Chain
12.2 Point of Care & Rapid Diagnostics Upstream Analysis
12.3 Point of Care & Rapid Diagnostics Midstream Analysis
12.4 Point of Care & Rapid Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioM茅rieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
听
听
*If Applicable.
